Phytotherapy for the prevention of atherosclerosis-associated early cerebral ischemia

Tatiana V. Kirichenko, Veronika A. Myasoedova, Igor A. Sobenin, Alexander N. Orekhov

Research output: Contribution to journalReview article

Abstract

Background: Cerebrovascular disease caused by atherosclerosis affecting cerebral and pre-cerebral arteries is one of the leading causes of morbidity and mortality in high-income countries. Medications of botanical origin are often characterized by good tolerability and are suitable for long-term treatment. Therefore, phytotherapy provides an interesting possibility for developing new therapies for the prevention of atherosclerosis and its complications that could be used at preclinical stages of the disease. Objective: We reviewed the current literature studying the potential of various plant-based medications for prevention and treatment of early cerebral ischemia induced by atherosclerosis. Methods: Literature search was performed in PubMed, Scopus, and Cochrane library to find trials on phytotherapy in cerebrovascular prevention and treatment. Results: The present review covers the recent data on the prevention of cerebral ischemia with natural preparations and demonstrates the effect of anti-atherosclerotic therapy on the dynamics of minor neurological changes. Conclusion: Phytotherapy appears to have a great potential for cerebrovascular disease prevention, combining good safety profiles with pleiotropic effects on different mechanisms atherosclerosis-related cerebral ischemia development.

Original languageEnglish
Pages (from-to)408-413
Number of pages6
JournalCurrent Drug Metabolism
Volume19
Issue number5
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Phytotherapy
Brain Ischemia
Atherosclerosis
Cerebrovascular Disorders
Intracranial Arteriosclerosis
Therapeutics
Cerebral Arteries
PubMed
Libraries
Morbidity
Safety
Mortality

Keywords

  • Atherosclerosis
  • Carotid IMT
  • Cerebral ischemia
  • Cerebrovascular disease
  • Natural preparation
  • Phytotherapy

ASJC Scopus subject areas

  • Pharmacology
  • Clinical Biochemistry

Cite this

Phytotherapy for the prevention of atherosclerosis-associated early cerebral ischemia. / Kirichenko, Tatiana V.; Myasoedova, Veronika A.; Sobenin, Igor A.; Orekhov, Alexander N.

In: Current Drug Metabolism, Vol. 19, No. 5, 01.01.2018, p. 408-413.

Research output: Contribution to journalReview article

Kirichenko, Tatiana V. ; Myasoedova, Veronika A. ; Sobenin, Igor A. ; Orekhov, Alexander N. / Phytotherapy for the prevention of atherosclerosis-associated early cerebral ischemia. In: Current Drug Metabolism. 2018 ; Vol. 19, No. 5. pp. 408-413.
@article{3c385ebfd8384ef0bcd65a1aa20a3ed4,
title = "Phytotherapy for the prevention of atherosclerosis-associated early cerebral ischemia",
abstract = "Background: Cerebrovascular disease caused by atherosclerosis affecting cerebral and pre-cerebral arteries is one of the leading causes of morbidity and mortality in high-income countries. Medications of botanical origin are often characterized by good tolerability and are suitable for long-term treatment. Therefore, phytotherapy provides an interesting possibility for developing new therapies for the prevention of atherosclerosis and its complications that could be used at preclinical stages of the disease. Objective: We reviewed the current literature studying the potential of various plant-based medications for prevention and treatment of early cerebral ischemia induced by atherosclerosis. Methods: Literature search was performed in PubMed, Scopus, and Cochrane library to find trials on phytotherapy in cerebrovascular prevention and treatment. Results: The present review covers the recent data on the prevention of cerebral ischemia with natural preparations and demonstrates the effect of anti-atherosclerotic therapy on the dynamics of minor neurological changes. Conclusion: Phytotherapy appears to have a great potential for cerebrovascular disease prevention, combining good safety profiles with pleiotropic effects on different mechanisms atherosclerosis-related cerebral ischemia development.",
keywords = "Atherosclerosis, Carotid IMT, Cerebral ischemia, Cerebrovascular disease, Natural preparation, Phytotherapy",
author = "Kirichenko, {Tatiana V.} and Myasoedova, {Veronika A.} and Sobenin, {Igor A.} and Orekhov, {Alexander N.}",
year = "2018",
month = "1",
day = "1",
doi = "10.2174/1389200219666180305151601",
language = "English",
volume = "19",
pages = "408--413",
journal = "Current Drug Metabolism",
issn = "1389-2002",
publisher = "Bentham Science Publishers B.V.",
number = "5",

}

TY - JOUR

T1 - Phytotherapy for the prevention of atherosclerosis-associated early cerebral ischemia

AU - Kirichenko, Tatiana V.

AU - Myasoedova, Veronika A.

AU - Sobenin, Igor A.

AU - Orekhov, Alexander N.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Cerebrovascular disease caused by atherosclerosis affecting cerebral and pre-cerebral arteries is one of the leading causes of morbidity and mortality in high-income countries. Medications of botanical origin are often characterized by good tolerability and are suitable for long-term treatment. Therefore, phytotherapy provides an interesting possibility for developing new therapies for the prevention of atherosclerosis and its complications that could be used at preclinical stages of the disease. Objective: We reviewed the current literature studying the potential of various plant-based medications for prevention and treatment of early cerebral ischemia induced by atherosclerosis. Methods: Literature search was performed in PubMed, Scopus, and Cochrane library to find trials on phytotherapy in cerebrovascular prevention and treatment. Results: The present review covers the recent data on the prevention of cerebral ischemia with natural preparations and demonstrates the effect of anti-atherosclerotic therapy on the dynamics of minor neurological changes. Conclusion: Phytotherapy appears to have a great potential for cerebrovascular disease prevention, combining good safety profiles with pleiotropic effects on different mechanisms atherosclerosis-related cerebral ischemia development.

AB - Background: Cerebrovascular disease caused by atherosclerosis affecting cerebral and pre-cerebral arteries is one of the leading causes of morbidity and mortality in high-income countries. Medications of botanical origin are often characterized by good tolerability and are suitable for long-term treatment. Therefore, phytotherapy provides an interesting possibility for developing new therapies for the prevention of atherosclerosis and its complications that could be used at preclinical stages of the disease. Objective: We reviewed the current literature studying the potential of various plant-based medications for prevention and treatment of early cerebral ischemia induced by atherosclerosis. Methods: Literature search was performed in PubMed, Scopus, and Cochrane library to find trials on phytotherapy in cerebrovascular prevention and treatment. Results: The present review covers the recent data on the prevention of cerebral ischemia with natural preparations and demonstrates the effect of anti-atherosclerotic therapy on the dynamics of minor neurological changes. Conclusion: Phytotherapy appears to have a great potential for cerebrovascular disease prevention, combining good safety profiles with pleiotropic effects on different mechanisms atherosclerosis-related cerebral ischemia development.

KW - Atherosclerosis

KW - Carotid IMT

KW - Cerebral ischemia

KW - Cerebrovascular disease

KW - Natural preparation

KW - Phytotherapy

UR - http://www.scopus.com/inward/record.url?scp=85048964931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048964931&partnerID=8YFLogxK

U2 - 10.2174/1389200219666180305151601

DO - 10.2174/1389200219666180305151601

M3 - Review article

C2 - 29512455

AN - SCOPUS:85048964931

VL - 19

SP - 408

EP - 413

JO - Current Drug Metabolism

JF - Current Drug Metabolism

SN - 1389-2002

IS - 5

ER -